Isere Kuiatse

1.6k citations
36 papers · 946 indexed · h-index 16

Isere Kuiatse

35 papers receiving 938 citations

Peers

Isere Kuiatse
Comparison fields: 5 of 73
  • Hematology 215
  • Cancer Research 172
  • Endocrinology, Diabetes and Metabolism 169
  • Molecular Biology 682
  • Oncology 268
Replace Mark Miglarese with:
Mark Miglarese United States
Dongdong Feng China
Shou‐Ih Hu United States
Sagarika Ray United States
Stefania Trino Italy
Chun-Ju Chang United States
Manoj M. Pillai United States
Vanessa Desantis Italy
May S.K. Sutherland United States
Janina E. E. Tirnitz‐Parker Australia
Isere Kuiatse relative to Mark Miglarese United States Mark Miglarese's profile →
Citations per field
00.5×4.9×
Mark Miglarese · 1×
Citations per year

Countries citing papers authored by Isere Kuiatse

Since Specialization
Citations

This map shows the geographic impact of Isere Kuiatse's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Isere Kuiatse with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Isere Kuiatse more than expected).

Fields of papers citing papers by Isere Kuiatse

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Isere Kuiatse. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Isere Kuiatse. The network helps show where Isere Kuiatse may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Isere Kuiatse, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Isere Kuiatse Line = papers co-authored together Isere Kuiatse links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown
#Work
1 20252
2 20240
3 20231
4 20209
5 20206
6 201957
7 201814
8 20164
9 201516
10 201560
11 201426
12 201414
13 201324
14 201399
15 20117
16 201137
17 201070
18 200833
19 200662
20 200691

About Isere Kuiatse

Isere Kuiatse is a scholar working on Hematology, Endocrinology, Diabetes and Metabolism and Oncology, having authored 36 papers that have together received 946 indexed citations. Recurring topics across this work include Multiple Myeloma Research and Treatments (19 papers), Protein Degradation and Inhibitors (12 papers), Ubiquitin and proteasome pathways (12 papers), Growth Hormone and Insulin-like Growth Factors (7 papers), Chronic Lymphocytic Leukemia Research (4 papers), Peptidase Inhibition and Analysis (4 papers), Chronic Myeloid Leukemia Treatments (3 papers) and Cancer Cells and Metastasis (3 papers). The work is most often cited by research in Hematology (215 citations), Cancer Research (172 citations) and Endocrinology, Diabetes and Metabolism (169 citations). Isere Kuiatse has collaborated with scholars based in United States, China and Belgium. Frequent co-authors include Adrian V. Lee, Robert Z. Orlowski, Xiaojiang Cui, Richard J. Jones, Darryl L. Hadsell, Hua Wang, Chad C. Bjorklund, Veerabhadran Baladandayuthapani, ZaWaunyka Lazard and Armando E. Giuliano. Their work appears in journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Blood.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026